Research and Analytics
In the News
Research and Analytics
COVID Research Articles
Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19
New research shows early intervention could slow the progression of COVID-19.
Remdesivir for 5 to 10 days in Patients with Severe COVID-19
Patients with severe cases of COVID-19 were treated with Remdesivir for 5 and 10 days to determine efficacy of the duration of treatment.
Immunological manipulations to lessen the severity of COVID-19
Article featuring multiple Providence doctors published in the Journal for ImmunoTherapy of Cancer focused on immunological manipulations to lessen the severity of COVID-19.
Clinical Support: An Unconventional Request – Providence’s 100 Million Masks Initiative
How the clinical support team at Providence met an unprecedented challenge.
NEJM: First Case of 2019 Novel Coronavirus in the United States
This report covers the first case of 2019-nCoV infection confirmed in the United States and describes the identification, diagnosis, clinical course, and management of the case.
Insights from immuno-oncology
The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic
This document identifies the potential risks of exposure to patients, allied health care staff, industry representatives and hospital administrators.
Put a lid on it: Are faecal bio-aerosols a route of transmission for SARS-CoV-2?
Gastrointestinal manifestations of COVID-19 are immediately reminiscent of previous coronavirus outbreaks and should raise concern about faecal shedding as a mode of transmission.
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
Described in this case series are the first 12 US patients confirmed to have COVID-19 from January 20 to February 5, 2020.
NEJM: Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
This study in the New England Journal of medicine examines clinical data from 24 COVID positive patients.
Dr. Diaz Explains Providence Response with NEJM
In an interview with the New England Journal of Medicine, Dr. George Diaz, chief of infectious diseases at Providence Regional Medical Center Everett, explains how Providence responded to the first U.